Efficacy and safety of OPANA ER (oxymorphone extended release) for relief of moderate to severe chronic low back pain in opioid-experienced patients: a 12-week, randomized, double-blind, placebo-controlled study.

Hale, Martin E; Ahdieh, Harry; Ma, Tina; Rauck, Richard

Hale, Martin E; Ahdieh, Harry; Ma, Tina; Rauck, Richard.

Affiliation

Hale ME; Gold Coast Research, LLC, Weston, Florida, USA.

J Pain ; 8(2): 175-84, 2007 Feb.

Article in En | MEDLINE | ID: mdl-17145204

Subject(s)

Analgesics, Opioid/administration & dosage; Low Back Pain/drug therapy; Morphine Derivatives/administration & dosage; Severity of Illness Index; Adult; Analgesics, Opioid/adverse effects; Chronic Disease; Delayed-Action Preparations; Double-Blind Method; Female; Humans; Male; Middle Aged; Morphine Derivatives/adverse effects; Oxymorphone; Pain Measurement; Patient Satisfaction; Placebos; Treatment Outcome

Search on Google

XML

PubMed Links

Database: MEDLINE Main subject: Severity of Illness Index / Low Back Pain / Analgesics, Opioid / Morphine Derivatives Type of study: Clinical_trials Limits: Adult / Female / Humans / Male / Middle aged Language: En Year: 2007 Type: Article

Search on Google

XML

PubMed Links